48th week of 2018 patent applcation highlights part 6 |
Patent application number | Title | Published |
20180338907 | TREATMENT OF RAYNAUD`S PHENOMENON BY INHIBITION OF TRANSIENT RECEPTOR POTENTIAL MELASTATIN-8 (TRPM-8) | 2018-11-29 |
20180338908 | INTRAVENOUS ADMINISTRATION OF TRAMADOL | 2018-11-29 |
20180338909 | INTRAVENOUS ADMINISTRATION OF TRAMADOL | 2018-11-29 |
20180338910 | INTRANASAL ADMINISTRATION OF GLUTAMATE CARBOXYPEPTIDASE (GCP-II) INHIBITORS | 2018-11-29 |
20180338911 | Eye Drops | 2018-11-29 |
20180338912 | MEDICAL DEVICES INCLUDING MEDICAMENTS AND METHODS OF MAKING AND USING SAME | 2018-11-29 |
20180338913 | ANTIHISTAMINE COMPOSITIONS, COMBINATIONS, AND USE THEREOF | 2018-11-29 |
20180338914 | DIRECT SODIUM REMOVAL METHOD, SOLUTION AND APPARATUS TO REDUCE FLUID OVERLOAD IN HEART FAILURE PATIENTS | 2018-11-29 |
20180338915 | PHARMACEUTICAL COMPOSITIONS OF AMORPHOUS DISPERSIONS OF DRUGS AND LIPOPHILIC MICROPHASE-FORMING MATERIALS | 2018-11-29 |
20180338916 | FOAM-FORMING COMPOSITIONS FOR DELIVERING AN ACTIVE TO A BODY CAVITY | 2018-11-29 |
20180338917 | COMPOSITIONS FOR DELIVERY OF DRUG COMBINATIONS | 2018-11-29 |
20180338918 | TEMSIROLIMUS LIPOSOME AND PREPARATION METHOD THEREOF | 2018-11-29 |
20180338919 | AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS | 2018-11-29 |
20180338920 | APPARATUS AND METHOD FOR CRYOGRANULATING A PHARMACEUTICAL COMPOSITION | 2018-11-29 |
20180338921 | FREEZE-DRIED ALGINIC ACID PREPARATION | 2018-11-29 |
20180338922 | FIXED DOSE FORMULATIONS | 2018-11-29 |
20180338923 | FORMULATIONS FOR DELIVERING INSULIN | 2018-11-29 |
20180338924 | SOLID PHARMACEUTICAL DOSAGE FORM FOR RELEASE OF AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT IN THE ORAL CAVITY | 2018-11-29 |
20180338925 | Implantable Naltrexone Tablets | 2018-11-29 |
20180338926 | 3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-Y- LIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE) | 2018-11-29 |
20180338927 | ETHER CELLULOSE DERIVATIVE MICROPARTICLE | 2018-11-29 |
20180338928 | METHODS OF TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) USING CYSTEAMINE COMPOUNDS | 2018-11-29 |
20180338929 | Method and Compounds for Treating Peripheral Neuropathy | 2018-11-29 |
20180338930 | MYRCENE-CONTAINING COMPLEX MIXTURES TARGETING TRPV1 | 2018-11-29 |
20180338931 | Use of Cannabinoids in the Treatment of Epilepsy | 2018-11-29 |
20180338932 | COMPOSITIONS AND METHODS OF TREATMENT FOR MVID AND RELATED DISEASES | 2018-11-29 |
20180338933 | Compositions And Methods Useful For Treatment Of Respiratory Illness | 2018-11-29 |
20180338934 | POLYAMINE DERIVATIVE MEDICINAL SALT AND PREPARATION METHOD AND USE | 2018-11-29 |
20180338935 | Combination For The Effective Treatment Of Metastatic Cancer In Patients | 2018-11-29 |
20180338936 | Methods and Compositions for the Treatment and Prevention of Allergic Rhinitis | 2018-11-29 |
20180338937 | PHARMACEUTICAL PREPARATIONS | 2018-11-29 |
20180338938 | DOPAMINERGIC MIMETICS | 2018-11-29 |
20180338939 | METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEDG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEDG | 2018-11-29 |
20180338940 | IMMUNOMODULATORY AND DIFFERENTIATING FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY | 2018-11-29 |
20180338941 | RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY | 2018-11-29 |
20180338942 | COMPOSITIONS COMPRISING CITRULLINE AND LEUCINE AND THEIR USE IN THE TREATMENT OF DIABETES AND METABOLIC SYNDROME | 2018-11-29 |
20180338943 | POSITION-SPECIFIC ASYMMETRIC DEUTERIUM ENRICHED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS | 2018-11-29 |
20180338944 | PHARMACEUTICAL COMPOSITIONS COMPRISING LEVODOPA, A DOPAMINE DECARBOXYLASE INHIBITOR AND A COMT INHIBITOR AND METHOD OF ADMINISTRATION THEREOF | 2018-11-29 |
20180338945 | SKIN ADHESIVES, ANTIMICROBIAL COMPOSITIONS, ARTICLES, AND METHODS FOR THE USE THEREOF | 2018-11-29 |
20180338946 | PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE | 2018-11-29 |
20180338947 | COMPOSITIONS FOR ANTI-INFLAMMATORY, ANTIOXIDANT EFFECTS AND IMPROVED RESPIRATORY FUNCTION BY SPECIFIC HISTONE DEACETYLASE INHIBITION | 2018-11-29 |
20180338948 | METHODS FOR TREATING PULMONARY FIBROSIS USING CHROMENONE DERIVATIVES | 2018-11-29 |
20180338949 | METHOD OF TREATMENT OF PREVENTING HYPERGLYCEMIA COMPLICATIONS | 2018-11-29 |
20180338950 | Prevention or Treatment of Disease States Due to Metal Dis-Homeostasis Via Administration of Posiphen to Healthy or Sick Humans | 2018-11-29 |
20180338951 | TREATMENTS FOR ARTERIAL STIFFENING, HYPERTENSION AND ANTI-AGING | 2018-11-29 |
20180338952 | COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING OCULAR DISORDERS | 2018-11-29 |
20180338953 | Compositions and Methods for Non-Surgical Treatment of Ptosis | 2018-11-29 |
20180338954 | USES OF BENZIMIDAZOLE DERIVATIVE FOR NOCTURNAL ACID BREAKTHROUGH | 2018-11-29 |
20180338955 | METHODS FOR REGULATION AND TREATMENT OF GLIOMA CELL MIGRATION AND GLIOBLASTOMA | 2018-11-29 |
20180338956 | COMBINED THERAPY FOR NMDAR ANTAGONIST-RESPONSIVE NEUROPSYCHIATRIC DISORDERS | 2018-11-29 |
20180338957 | ANTIMICROBIAL AGENTS | 2018-11-29 |
20180338958 | METHOD OF TREATMENT USING INHIBITORS OF MITOSIS | 2018-11-29 |
20180338959 | TREATMENT OF DEPRESSIVE DISORDERS | 2018-11-29 |
20180338960 | METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL | 2018-11-29 |
20180338961 | BIOMARKER OF POLYCYSTIC KIDNEY DISEASE AND USES THEREOF | 2018-11-29 |
20180338962 | METHODS OF USE OF CYCLOPAMINE ANALOGS | 2018-11-29 |
20180338963 | DONOR ORGAN PRE-TREATMENT FORMULATION | 2018-11-29 |
20180338964 | 3-(PIPERIDIN-4-YL)-ISOXAZOL-3(OH)-ONES FOR TREATMENT OF DERMATOLOGIC DISORDERS | 2018-11-29 |
20180338965 | MONOSUBSTITUTED OR POLYSUBSTITUTED AMPHIPHILIC HYPOCRELLIN DERIVATIVE, AND PREPARATION METHOD AND APPLICATION THEREOF | 2018-11-29 |
20180338966 | Treating Pain In Patients With Hepatic Impairment | 2018-11-29 |
20180338967 | OXYMORPHONE CONTROLLED RELEASE COMPOSITIONS | 2018-11-29 |
20180338968 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | 2018-11-29 |
20180338969 | THERAPEUTIC APPROACHES FOR TREATING CMT AND RELATED DISORDERS | 2018-11-29 |
20180338970 | PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY | 2018-11-29 |
20180338971 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CUSHING'S SYNDROME USING 2S, 4R KETOCONAZOLE | 2018-11-29 |
20180338972 | ANTHELMINTIC COMPOUNDS | 2018-11-29 |
20180338973 | PYRIMIDINE DERIVATIVE AND USE THEREOF | 2018-11-29 |
20180338974 | IMIDAZOLIDINEDIONE DERIVATIVES | 2018-11-29 |
20180338975 | DRUG WITH HEPATOPROTECTIVE ACTIVITY | 2018-11-29 |
20180338976 | METHOD FOR TREATING CANCER PATIENTS WITH SEVERE RENAL IMPAIRMENT | 2018-11-29 |
20180338977 | HUMAN PAPILLOMA VIRUS AS PREDICTOR OF CANCER PROGNOSIS | 2018-11-29 |
20180338978 | HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS | 2018-11-29 |
20180338979 | Method of Adjuvant Cancer Treatment | 2018-11-29 |
20180338980 | AROMATIC SULFONAMIDE DERIVATIVES | 2018-11-29 |
20180338981 | Process for Preparing Ceftolozane from 7-Aminocephalosporanic Acid (7-ACA) | 2018-11-29 |
20180338982 | Cooperative Medication Combination Systems | 2018-11-29 |
20180338983 | FORMULATIONS FOR TREATMENT OF POST-TRAUMATIC STRESS DISORDER | 2018-11-29 |
20180338984 | TIANEPTINE OXALATE SALTS AND POLYMORPHS | 2018-11-29 |
20180338985 | METHODS AND PRODUCTS FOR PREVENTING AND/OR TREATING MICROORGANISM INFECTIONS COMPRISING IRON CHELATORS AND NON-IRON PORPHYRINS | 2018-11-29 |
20180338986 | TOPICAL FORMULATIONS COMPRISING A STEROID | 2018-11-29 |
20180338987 | SYNTHETIC BILE ACID COMPOSITIONS AND METHODS | 2018-11-29 |
20180338988 | COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS | 2018-11-29 |
20180338989 | COMPOUNDS FOR THE TREATMENT OF ADDICTION | 2018-11-29 |
20180338990 | Reduced Pressure Maillard Synthesis of Carbohydrate Energy Supplement for Ruminant Livestock | 2018-11-29 |
20180338991 | NAD BIOSYNTHESIS AND PRECURSORS FOR THE TREATMENT AND PREVENTION OF CANCER AND PROLIFERATION | 2018-11-29 |
20180338992 | IL-34 ANTISENSE OLIGONUCLEOTIDES AND METHODS OF USING SAME | 2018-11-29 |
20180338993 | TREATMENT OF HEPATITIS DELTA VIRUS INFECTION | 2018-11-29 |
20180338994 | Anti-Virus Agent and Method for Treatment of Viral Infection | 2018-11-29 |
20180338995 | SYSTEMS AND METHODS FOR TREATMENTS USING HYDROGEN AND/OR NOBLE GASES | 2018-11-29 |
20180338996 | COMBINATION THERAPY FOR TRAUMATIC BRAIN INJURY | 2018-11-29 |
20180338997 | THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS | 2018-11-29 |
20180338998 | Methods and Materials for Treating Nerve Injuries and Neurological Disorders | 2018-11-29 |
20180338999 | SOFT TISSUE REPAIR AND REGENERATION USING POSTPARTUM-DERIVED CELLS AND CELL PRODUCTS | 2018-11-29 |
20180339000 | USE OF NEURAL CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2018-11-29 |
20180339001 | USE OF NEURAL CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2018-11-29 |
20180339002 | METHODS FOR TREATING NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B CELL (NF-KB) DYSREGULATION IN A HOST IN NEED THEREOF USING EGGSHELL MEMBRANE COMPOSITIONS | 2018-11-29 |
20180339003 | PARENTERAL DELIVERY DEVICE AND METHODS OF USE | 2018-11-29 |
20180339004 | ONCOLYTIC VIRAL VECTORS AND USES THEREOF | 2018-11-29 |
20180339005 | Liquid Composition for Reconstituting Pressed Powder Cosmetics | 2018-11-29 |
20180339006 | METHOD FOR PREPARING GRANULES OR PILLS CONTAINING EXTRACTS IN HIGH CONCENTRATION | 2018-11-29 |